• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人十二指肠肠内分泌细胞:肠促胰岛素肽GLP-1和GIP的来源。

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

作者信息

Theodorakis Michael J, Carlson Olga, Michopoulos Spyros, Doyle Máire E, Juhaszova Magdalena, Petraki Kalliopi, Egan Josephine M

机构信息

Diabetes Section, Laboratory of Clinical Investigation, National Institute of Health, Baltimore, MD 21224, USA.

出版信息

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E550-9. doi: 10.1152/ajpendo.00326.2004. Epub 2005 Oct 11.

DOI:10.1152/ajpendo.00326.2004
PMID:16219666
Abstract

Among the products of enteroendocrine cells are the incretins glucagon-like peptide-1 (GLP-1, secreted by L cells) and glucose-dependent insulinotropic peptide (GIP, secreted by K cells). These are key modulators of insulin secretion, glucose homeostasis, and gastric emptying. Because of the rapid early rise of GLP-1 in plasma after oral glucose, we wished to definitively establish the absence or presence of L cells, as well as the relative distribution of the incretin cell types in human duodenum. We confirmed the presence of proglucagon and pro-GIP genes, their products, and glucosensory molecules by tissue immunohistochemistry and RT-PCR of laser-captured, single duodenal cells. We also assayed plasma glucose, incretin, and insulin levels in subjects with normal glucose tolerance and type 2 diabetes for 120 min after they ingested 75 g of glucose. Subjects with normal glucose tolerance (n=14) had as many L cells (15+/-1), expressed per 1,000 gut epithelial cells, as K cells (13+/-1), with some containing both hormones (L/K cells, 5+/-1). In type 2 diabetes, the number of L and L/K cells was increased (26+/-2; P<0.001 and 9+/-1; P < 0.001, respectively). Both L and K cells contained glucokinase and glucose transporter-1, -2, and -3. Newly diagnosed type 2 diabetic subjects had increased plasma GLP-1 levels between 20 and 80 min, concurrently with rising plasma insulin levels. Significant coexpression of the main incretin peptides occurs in human duodenum. L and K cells are present in equal numbers. New onset type 2 diabetes is associated with a shift to the L phenotype.

摘要

肠内分泌细胞的产物包括肠促胰岛素胰高血糖素样肽-1(GLP-1,由L细胞分泌)和葡萄糖依赖性促胰岛素多肽(GIP,由K细胞分泌)。这些是胰岛素分泌、葡萄糖稳态和胃排空的关键调节因子。由于口服葡萄糖后血浆中GLP-1迅速早期升高,我们希望明确确定人十二指肠中L细胞的有无以及肠促胰岛素细胞类型的相对分布。我们通过组织免疫组化和激光捕获的单个十二指肠细胞的逆转录聚合酶链反应(RT-PCR)证实了胰高血糖素原和GIP原基因、它们的产物以及葡萄糖感应分子的存在。我们还在糖耐量正常和2型糖尿病患者摄入75克葡萄糖后120分钟内检测了他们的血浆葡萄糖、肠促胰岛素和胰岛素水平。糖耐量正常的受试者(n = 14)每1000个肠上皮细胞中L细胞(15±1)的数量与K细胞(13±1)相同,有些细胞同时含有两种激素(L/K细胞,5±1)。在2型糖尿病患者中,L细胞和L/K细胞的数量增加(分别为26±2;P<0.001和9±1;P<0.001)。L细胞和K细胞都含有葡萄糖激酶以及葡萄糖转运蛋白-1、-2和-3。新诊断的2型糖尿病患者在20至80分钟之间血浆GLP-1水平升高,同时血浆胰岛素水平也在上升。主要肠促胰岛素肽在人十二指肠中存在显著共表达。L细胞和K细胞数量相等。新发2型糖尿病与向L表型的转变有关。

相似文献

1
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.人十二指肠肠内分泌细胞:肠促胰岛素肽GLP-1和GIP的来源。
Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E550-9. doi: 10.1152/ajpendo.00326.2004. Epub 2005 Oct 11.
2
Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.血糖正常、糖耐量受损和糖尿病患者体内肠促胰岛素浓度的预测因素。
Diabetes. 2008 Mar;57(3):678-87. doi: 10.2337/db07-1124. Epub 2007 Dec 5.
3
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.2型糖尿病患者一级亲属口服葡萄糖后肠促胰岛素激素(GIP和GLP-1)的分泌及肠促胰岛素效应
Regul Pept. 2004 Nov 15;122(3):209-17. doi: 10.1016/j.regpep.2004.06.020.
4
Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.最初更快的小肠葡萄糖输送会增加血浆胰岛素、GIP和GLP-1,但并不能改善健康受试者的整体血糖水平。
Am J Physiol Endocrinol Metab. 2005 Sep;289(3):E504-7. doi: 10.1152/ajpendo.00099.2005. Epub 2005 May 10.
5
[Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].胰高血糖素样肽-1(GLP-1)类似物:作为2型糖尿病患者新治疗方法的一个旧概念
Ned Tijdschr Geneeskd. 2004 Sep 25;148(39):1912-7.
6
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.在肥胖的II型糖尿病患者中,葡萄糖依赖性促胰岛素多肽(GIP)对葡萄糖的晚期胰岛素反应放大存在缺陷。
Diabetologia. 2002 Aug;45(8):1111-9. doi: 10.1007/s00125-002-0878-6. Epub 2002 Jul 4.
7
Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.2型糖尿病患者口服蔗糖后,由于α-葡萄糖苷酶抑制(阿卡波糖)导致胰高血糖素样肽1(7-36酰胺)分泌延长且增强。
Diabet Med. 1998 Jun;15(6):485-91. doi: 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y.
8
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.多囊卵巢综合征女性的肠促胰岛素分泌:肥胖、胰岛素敏感性及二甲双胍治疗的作用
Metabolism. 2009 May;58(5):586-93. doi: 10.1016/j.metabol.2008.11.009.
9
Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.空肠旁路术保护 GK 大鼠β细胞丢失和加重高血糖,并增加共同表达 GIP 和 GLP-1 的肠内分泌细胞。
Am J Physiol Endocrinol Metab. 2011 May;300(5):E923-32. doi: 10.1152/ajpendo.00422.2010. Epub 2011 Feb 8.
10
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.接受抗逆转录病毒治疗的糖耐量异常HIV感染患者口服葡萄糖后胰高血糖素样肽-1(GLP-1)反应增强。
HIV Med. 2005 Mar;6(2):91-8. doi: 10.1111/j.1468-1293.2005.00270.x.

引用本文的文献

1
Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis.肥胖受试者的十二指肠神经内分泌细胞与神经降压素U:与2型糖尿病及葡萄糖稳态的关系。
Physiol Rep. 2025 Aug;13(15):e70489. doi: 10.14814/phy2.70489.
2
New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity.调节小儿肥胖症肠-胰岛轴的新视角
Int J Mol Sci. 2025 Jun 26;26(13):6143. doi: 10.3390/ijms26136143.
3
Effect of GIP and GLP-1 infusion on bone resorption in glucose intolerant, pancreatic insufficient cystic fibrosis.
葡萄糖耐量异常、胰腺功能不全的囊性纤维化患者中,输注胃抑肽(GIP)和胰高血糖素样肽-1(GLP-1)对骨吸收的影响
J Clin Transl Endocrinol. 2025 Apr 7;40:100392. doi: 10.1016/j.jcte.2025.100392. eCollection 2025 Jun.
4
Glucose-dependent insulinotropic polypeptide (GIP).葡萄糖依赖性促胰岛素多肽(GIP)。
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
5
Rapid stimulation of protein synthesis in digesting snakes: Unveiling a novel gut-pancreas-muscle axis.消化期蛇类蛋白质合成的快速刺激:揭示一条新的肠-胰腺-肌肉轴
Acta Physiol (Oxf). 2025 Feb;241(2):e70006. doi: 10.1111/apha.70006.
6
Cannabinoids Block Fat-induced Incretin Release via CB-dependent and CB-independent Pathways in Intestinal Epithelium.大麻素通过肠道上皮细胞中依赖CB和不依赖CB的途径阻断脂肪诱导的肠促胰岛素释放。
Gastro Hep Adv. 2024 Jul 22;3(7):931-941. doi: 10.1016/j.gastha.2024.07.006. eCollection 2024.
7
The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease.肠道微生物群、短链脂肪酸之间的相互作用及其对宿主健康和疾病的影响。
Gut Microbes. 2024 Jan-Dec;16(1):2393270. doi: 10.1080/19490976.2024.2393270. Epub 2024 Sep 16.
8
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study.代谢心血管、饮食和生活方式参数与血浆胰高血糖素样肽-1 的关系:一项 IMI DIRECT 研究。
J Clin Endocrinol Metab. 2024 Aug 13;109(9):e1697-e1707. doi: 10.1210/clinem/dgae119.
9
Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes.葡萄糖激酶激活剂在糖尿病葡萄糖稳态恢复中的临床研究。
J Diabetes. 2024 May;16(5):e13544. doi: 10.1111/1753-0407.13544.
10
Update on Endoscopic Treatments for Obesity.肥胖症内镜治疗的最新进展
Curr Obes Rep. 2024 Jun;13(2):364-376. doi: 10.1007/s13679-024-00551-6.